171 related articles for article (PubMed ID: 28721365)
1. Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer.
Bashir M; Damineni S; Mukherjee G; Kondaiah P
NPJ Breast Cancer; 2015; 1():15007. PubMed ID: 28721365
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway.
Yuan CL; Liang R; Liu ZH; Li YQ; Luo XL; Ye JZ; Lin Y
Exp Ther Med; 2018 Jun; 15(6):5422-5430. PubMed ID: 29805551
[TBL] [Abstract][Full Text] [Related]
3. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.
Bauer J; Ozden O; Akagi N; Carroll T; Principe DR; Staudacher JJ; Spehlmann ME; Eckmann L; Grippo PJ; Jung B
Mol Cancer; 2015 Oct; 14():182. PubMed ID: 26497569
[TBL] [Abstract][Full Text] [Related]
4. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway.
Carl C; Flindt A; Hartmann J; Dahlke M; Rades D; Dunst J; Lehnert H; Gieseler F; Ungefroren H
Cell Mol Life Sci; 2016 Jan; 73(2):427-43. PubMed ID: 26238393
[TBL] [Abstract][Full Text] [Related]
6. Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.
Staudacher JJ; Bauer J; Jana A; Tian J; Carroll T; Mancinelli G; Özden Ö; Krett N; Guzman G; Kerr D; Grippo P; Jung B
Sci Rep; 2017 Jul; 7(1):5569. PubMed ID: 28717230
[TBL] [Abstract][Full Text] [Related]
7. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis.
Kalli M; Mpekris F; Wong CK; Panagi M; Ozturk S; Thiagalingam S; Stylianopoulos T; Papageorgis P
Front Oncol; 2019; 9():32. PubMed ID: 30805303
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.
Liu F; Wang K; Zhang L; Yang YL
Oncol Lett; 2018 Oct; 16(4):5113-5121. PubMed ID: 30250579
[TBL] [Abstract][Full Text] [Related]
11. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
12. Autocrine transforming growth factor-β/activin A-Smad signaling induces hepatic progenitor cells undergoing partial epithelial-mesenchymal transition states.
Wu Y; Ding ZY; Jin GN; Xiong YX; Yu B; Sun YM; Wang W; Liang HF; Zhang B; Chen XP
Biochimie; 2018 May; 148():87-98. PubMed ID: 29544731
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
14. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
17. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.
Seachrist DD; Sizemore ST; Johnson E; Abdul-Karim FW; Weber Bonk KL; Keri RA
Breast Cancer Res; 2017 Jun; 19(1):66. PubMed ID: 28583174
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
[TBL] [Abstract][Full Text] [Related]
19. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
